|
|
Adapthealth Corp (NASDAQ: AHCO) |
|
Price: $10.5200
$0.14 
1.349%
|
| Day's High:
| $10.545
| Week Perf:
| 1.84 %
|
| Day's Low: |
$ 10.23 |
30 Day Perf: |
5.2 % |
| Volume (M): |
600 |
52 Wk High: |
$ 11.90 |
| Volume (M$): |
$ 6,308 |
52 Wk Avg: |
$10.01 |
| Open: |
$10.42 |
52 Wk Low: |
$6.67 |
|
|
| Market Capitalization (Millions $) |
1,436 |
| Shares
Outstanding (Millions) |
137 |
| Employees |
1,016 |
| Revenues (TTM) (Millions $) |
3,263 |
| Net Income (TTM) (Millions $) |
-210 |
| Cash Flow (TTM) (Millions $) |
44 |
| Capital Exp. (TTM) (Millions $) |
317 |
Adapthealth Corp
Adapthealth Corp is a leading provider of home medical equipment and related services in the United States. The company specializes in the supply and distribution of home healthcare products and medical equipment, a sector that is rapidly expanding due to the aging population and the increasing prevalence of chronic diseases. Adapthealth serves both patients and healthcare providers, helping to improve the quality of care and the quality of life for those who need medical assistance.
Founded in 2016 with headquarters in Plymouth Meeting, Pennsylvania, Adapthealth has grown rapidly through a series of strategic acquisitions, bringing together companies with complementary products and services to create a broad, diverse, and experienced team of professionals. Adapthealth's mission is to provide personalized and comprehensive home healthcare solutions to patients and healthcare providers, while creating value for its shareholders and employees.
The company operates through several business segments, including Home Medical Equipment (HME), Sleep, Respiratory, and Diabetes. Its core product lines include oxygen therapy, mobility equipment, sleep therapy, and diabetes management supplies. Adapthealth also offers a range of support services such as product training, reimbursement assistance, and patient education.
Adapthealthes Home Medical Equipment (HME) segment offers a range of home medical equipment, such as power mobility equipment, wheelchairs, and home accessibility solutions. The Sleep segment focuses on sleep apnea and provides CPAP and BiPAP machines, masks, and associated supplies. Through its Respiratory segment, the company provides oxygen therapy, ventilators, and related equipment. Lastly, the Diabetes segment offers glucose monitoring and insulin delivery products, as well as related supplies.
Adapthealth operates through a combination of direct-to-patient services and partnerships with healthcare providers. The company has a nationwide network of over 300 locations, including distribution centers, call centers, and patient service centers. Additionally, Adapthealth has over 3,000 employees, including respiratory therapists, registered nurses, and pharmacy technicians.
Adapthealthes strong market position and growth prospects have attracted significant investment, including a recent merger with AeroCare Holdings, Inc. in 202 Following the merger, Adapthealth became a publicly traded company listed on the NASDAQ stock exchange.
Overall, Adapthealth is a dynamic and innovative company that is well-positioned to capitalize on the growing demand for home healthcare products and services in the United States. Its commitment to personalized care, technology, and customer service has earned it a reputation as a trusted provider of comprehensive and high-quality home medical equipment and support services.
Company Address: 220 West Germantown Pike Plymouth Meeting 19462 PA
Company Phone Number: 424-4515 Stock Exchange / Ticker: NASDAQ AHCO
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Wed, Jul 3 2024 4:27 AM UTC
AdaptHealth Corp. Appoints Dale Wolf as Chairman of the Board of DirectorsIn a recent announcement, AdaptHealth Corp., a leading provider of patient-centered healthcare-at-home solutions, revealed changes to its board of directors and management team. Effective July 1, 2024, Dale Wolf will assume the role of Chairman of the Board, taking over from outgoing Chairman Richard B...
|
| Adapthealth Corp
The recent financial results of AdaptHealth Corp show a mixed bag of outcomes. On one hand, the company reported an increase in net revenue for the fiscal year 2023, which is a positive sign of growth. Additionally, the company was able to reduce its loss per share and improve its income per share compared to the previous year.
However, there are some concerning aspects as well. The company experienced a decrease in revenue for the fiscal interval ending March 31, 2024, which could be a red flag for investors. Furthermore, AdaptHealth Corp saw a net shortfall in this period, as opposed to a net profit in the same reporting season a year before.
The fact that Adapthealth Corp shares have gone down by -2.98% in May 2024 so far, with a further decrease of -19.14% from a year before, suggests that investors may be reacting to these financial results. This decline in share price could be a reflection of concerns about the company's profitability and revenue growth.
|
| Adapthealth Corp
AdaptHealth Corp (NASDAQ: AHCO), a prominent player in the healthcare-at-home solutions sector, has recently released its financial results for the fourth quarter and fiscal year ending December 31, 2023. Despite facing a loss per share of $-1.91, a significant increase from the previous year's $-0.01, AdaptHealth Corp witnessed an impressive improvement in revenue by 9.99%, amounting to $858.23 million.
In the healthcare facilities industry, AdaptHealth Corp outperformed its competitors by achieving remarkable top-line growth in the fourth quarter of 2023. While most companies in the sector reported an average growth rate of 8.16% compared to the same period last year, AdaptHealth Corp surpassed expectations with its revenue growth.
|
| Adapthealth Corp
AdaptHealth Corp is a national leader in providing patient-centered, healthcare-at-home solutions. The company offers a wide range of home medical equipment, medical supplies, and related services, catering to the growing demand for at-home healthcare options. They recently announced their financial results for the third quarter ended on September 30, 2023.
During the July to September 2023 fiscal period, AdaptHealth Corp slipped into a deficit of $-3.43 per share, compared to earning $0.11 per share in the previous year. This decline in earnings per share (EPS) was also reflected in the sequential reporting season, with EPS falling from $0.09 per share. Despite this decrease in profitability, the company witnessed a growth in revenue. The revenue grew by 6.284% to $804.03 million from $756.50 million in the comparable reporting season of the previous year. Additionally, sequentially, the revenue grew by 1.354% from $793.29 million. However, it is noteworthy that AdaptHealth Corp's top-line gain came in lower than the 8.89% growth recorded by the rest of the Healthcare Facilities industry in Q3 of 2022.
|
| Adapthealth Corp
Financial News Report: Adapthealth Corp Maintains Profit, Increases Revenue, and Focuses on Sales Improvement
Adapthealth Corp (AHCO) reported its financial results for the fiscal interval ending June 30, 2023. The company's net profit per share remained unchanged at $0.09 per share compared to the previous year, while it turned positive from a loss of $-0.06 per share in the previous reporting period.
In terms of revenue, Adapthealth Corp experienced a notable increase of 9.026% to $793.29 million from $727.61 million in the same reporting period a year ago. Sequentially, the revenue advanced by 6.535% from $744.63 million. AHCO's top-line growth outperformed most of its industry peers in the Healthcare Facilities sector during the second quarter of 2023. The majority of businesses in the Healthcare Facilities industry had an average top-line growth of 7.97% compared to the same period the previous year.
However, despite the revenue growth, Adapthealth Corp saw a slight decline in net earnings. Net earnings for the fiscal interval ending June 30, 2023, were $15.041 million, a decrease of -1.35% from $15.247 million in the corresponding period the previous year.
Adapthealth Corp has shifted its focus to improving sales in the fiscal interval closing June 30, 2023. As a result, the company's net margin eased to 1.9%. Additionally, due to the seasonal nature of the business, inventories declined to $114.9 million from the previous quarter, but still marked an increase compared to the same period a year ago.
The company's operating earnings fell by -8.31% to $54.262 million, which caused Adapthealth Corp's operating margin to decrease to 6.84% from 8.13% in the second quarter of 2022.
Another indicator of rising demand for Adapthealth Corp's products and services is the increase in accounts receivable. The accounts receivable were valued at $365.7 million, higher than in the preceding quarter.
|
| Per Share |
Current |
| Earnings (TTM) |
-1.65 $ |
| Revenues (TTM) |
23.9 $
|
| Cash Flow (TTM) |
0.32 $ |
| Cash |
-
|
| Book Value |
11.16 $
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-1.65 $
|
| Revenues (TTM) |
23.9 $ |
| Cash Flow (TTM) |
0.32 $ |
| Cash |
-
|
| Book Value |
11.16 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
On February 27 2024 the Adapthealth provided following guidance
On February 27, 2024, AdaptHealth Corp. released its financial results for the fourth quarter and full year of 2023. The company reported a net revenue of $3,200 for the year, representing a significant increase compared to the previous year.
AdaptHealth Corp. continued to solidify its position as a national leader in providing healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company's focus on patient-centered care has contributed to its success in the healthcare industry.
Looking ahead to 2024, AdaptHealth Corp. provided an initial outlook, indicating positive growth and continued success for the company. The estimates for 2024 anti...
|
|
|
5.19%